Meet the Next Biggest Medical Company

Written by Charles Mizrahi
Posted December 19, 2017

Once you heard the air raid siren, you had only a few minutes to get your gas mask on and walk up to the “sealed room."

New York City, February 1991...

I was just about to leave my office when my intercom buzzed: “Mr. Miz, Michael on line 4.”

The last time Michael had called me, I'd ended up on a plane to the former Soviet Union 72 hours later. Michael had convinced me that if I didn’t go on this humanitarian mission, I would regret it for the rest of my life. He was right.

I wondered what this call would bring...

Michael and I were good friends. He was very well connected with the major philanthropic organizations in New York City. These organizations knew that in one call to Michael, they were getting someone very committed to making the world a better place.

He had the ability to bring passion to a project. And he was also able to raise millions of dollars in no time. I think they all had his number on speed dial.

Michael had built a very successful distribution company within only a few years. He was also restless. Michael loved traveling and adventure.

“Pack your bags,” he said on the phone. “I just got a call. We need to show solidarity. All the bigwigs are going on this one. We’ll be leaving tomorrow night from JFK. I’ll fill you in on the details later.” And then the phone went dead...

Duty Calls

Michael filled me in on the details on the way home. I was all for the trip, but there was no way my wife would give me the go ahead.

Saddam Hussein had invaded Kuwait in the summer of 1990 and installed a puppet government. Despite United Nations resolutions calling for the immediate withdrawal of Iraqi forces, Saddam didn't budge.

Saddam threatened to scorch Israel with chemical weapons if the U.S. came to Kuwait’s defense. He wanted to draw Israel into the fight. He was hoping that if Israel retaliated, it would damage the anti-Saddam coalition that included Arab countries. After missing several deadlines, the U.S. went to war in mid-January.

Almost immediately, Saddam made good on his threats. He launched Scud missiles at Israel’s largest cities, Tel Aviv and Haifa.

When Michael called me, there'd been more than 10 Scud landings in Israel. So far, all of the Scuds had conventional, instead of chemical, warheads.

That night at dinner, I built up the courage and asked for my wife’s permission. I told her how much this trip would mean — not only to the parents and the kids who were under attack but also to me. I felt I had to do something, and this was it.

She paused and said, “Just be careful.” I'm truly blessed to have such a great partner...

Gas Mask at the Ready

While we were in Tel Aviv, four Scuds were launched. Once you heard the air raid siren, you had only a few minutes to get your gas mask on, take your first aid kit, and walk up to the top floor of the building into the “sealed room.”

If the Scuds had chemical warheads, it would take more time for the poisonous gas to reach you.

Most of the Scuds were launched in the middle of the night. It was sheer terror. Listening to Scuds streaking across the night sky and then exploding on impact is a sound that I’ll never forget...

But I made it through and so did Israel...

When I returned to the U.S., I made it my mission to do the right thing both professionally and personally and, if I could, both at the same time.

That’s how I’ve led my entire investment career.

And it's also why when it comes to cancer, I've left no stone unturned in finding a cure.

Because of my personal experiences with the deadly disease (my mother has fought it twice), I've dedicated much of my time to and resources on researching a solution.

It’s taken many years, but I think we're nearing the point of curing cancer...

And that’s why I headed back to Israel to meet with one of the world’s leading pioneers against cancer.

His name is Dr. Zelig Eshhar...

Go Straight to the Top

Tel Aviv, Israel, December 2017...

I'd sent an email asking for a few minutes of his time for an interview.

I'd already spent two months researching biotech companies. And after reading about his revolutionary cancer treatment, I knew I had to meet him.

Kite Pharma paid $375,000 for the rights to Dr. Eshhar's chimeric antigen receptor T cell (CAR-T) therapy back in 2013. And this past summer, Gilead Sciences bought Kite for a whopping $11.9 billion.

In lab testing to date, a stunning 94% of those suffering from an acute form of leukemia went into full remission with this treatment, and this was after all other treatments had failed!

FDA commissioner Scott Gottlieb says, “We’re entering a new frontier in medical innovation...”

A week later, I received a reply from Dr. Eshhar: “Granted.”

I made the appointment for the following week. We met at the Tel Aviv Sourasky Medical Center.

I asked for just 10 minutes, but the professor of immunology gave me more than three hours of his time!

I kept thinking back to Einstein’s quote the more time I spent with the professor. “The definition of genius is taking the complex and making it simple.”

The professor explained CAR-T and how it works in very simple terms. With very little background in science, I still understood it...

School Is in Session

Dr. Eshhar taught me how T cells and antibodies are parts of our immune system and that both are capable of identifying tumor cells from normal cells. But there's a problem with this system: Cancer cells are smart. They know how to evade and avoid T cells.

While T cells are good at killing cancer cells, they have a hard time finding them. And antibodies are experts in finding cancer cells, but they can’t kill them. So, the professor’s solution is to combine them.

He drew this out on the whiteboard behind his desk. Ever the teacher, the professor asked me to explain it back to him. He wanted to make sure that I got it.

Being in Tel Aviv, the memories of the Scud attacks were on my mind. I asked if I could use an analogy to explain it.

“By all means,” he answered.

I told him that, to me, the T cells were like Scud missiles. They're able to do harm but didn’t have a guidance system. The CAR-T cell therapy takes T cells, fits them with a guidance system (antibodies), and then injects them into the patient. This new modified T cell is able to hone in on the cancer cells and destroy them.

He gave me a big broad smile. He liked my analogy.

As we shook hands at the end of our meeting, I asked if I could meet up him on my next trip.

“Of course, it would be my pleasure,” he said.

What’s the Cure for Cancer Worth?

In the coming days, you'll be able to get a copy of my exclusive research report on Dr. Eshhar’s breakthrough cancer-killing therapy and the company that’s pioneering it.

I'm urging you to be on the lookout for this report...

The company’s stock has been one of the best-performing medical treatment companies on the market with a stellar return of 349% over just two years.

But its run has just begun. After all, what’s the cure for cancer worth?

It's priceless, in my opinion.

This company has the potential of becoming one of the biggest health care stocks ever.

And I want you to be a part of this history-making company.

All my best,

Charles Mizrahi signature

Charles Mizrahi
Founder, Park Avenue Digest

follow basic@Park_Ave_Digest

Charles cut his chops on the trading floor of the New York Futures Exchange before he moved on to become a wildly successful money manager on Wall Street.

And with more than 35 years of recommending stocks under his belt, Charles has knocked the cover off the ball. He's compiled an amazing record of success and posted gain after gain for his loyal readers. He's the founder of Park Avenue Investment Club and Insider Alert newsletters.

Charles is also the author of the highly acclaimed book Getting Started in Value Investing.

Report: 5 Simple Rules
for Investing in a Bear Market